These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9508080)

  • 21. Prostate cancer incidence and survival in relation to education (United States).
    Steenland K; Rodriguez C; Mondul A; Calle EE; Thun M
    Cancer Causes Control; 2004 Nov; 15(9):939-45. PubMed ID: 15577296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSA testing in Austria: induced morbidity and saved mortality.
    Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
    Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota.
    Roberts RO; Bergstralh EJ; Katusic SK; Lieber MM; Jacobsen SJ
    J Urol; 1999 Feb; 161(2):529-33. PubMed ID: 9915441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of physical activity and incident and fatal prostate cancer.
    Giovannucci EL; Liu Y; Leitzmann MF; Stampfer MJ; Willett WC
    Arch Intern Med; 2005 May; 165(9):1005-10. PubMed ID: 15883238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The increasing incidence of prostate cancer in Hungary.
    Sapi Z; Bodo M; Vadasz G; Henson DE; Haas GP
    In Vivo; 1994; 8(3):433-5. PubMed ID: 7803729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is diabetes mellitus associated with prostate cancer incidence and survival?
    Will JC; Vinicor F; Calle EE
    Epidemiology; 1999 May; 10(3):313-8. PubMed ID: 10230844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment.
    Stotts RC
    Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology of prostate cancer in the Limousin area].
    Druet-Cabanac M; Colombeau P; Preux PM; Paulhac P; Vergnenegre A; Dumas JP
    Prog Urol; 2002 Apr; 12(2):226-31. PubMed ID: 12108336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The epidemiology of prostate cancer--recent trends in prostate cancer incidence and mortality].
    Sata F; Umemura T; Kishi R
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):184-8. PubMed ID: 11242644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimated impact of the Prostate Cancer Prevention Trial on population mortality.
    Unger JM; Thompson IM; LeBlanc M; Crowley JJ; Goodman PJ; Ford LG; Coltman CA
    Cancer; 2005 Apr; 103(7):1375-80. PubMed ID: 15739207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain)].
    Bernal M; Romero FJ; Souza DL; Gómez-Bernal FJ; Gómez-Bernal GJ
    Actas Urol Esp; 2011 Sep; 35(8):470-4. PubMed ID: 21621302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006.
    Cremers RG; Karim-Kos HE; Houterman S; Verhoeven RH; Schröder FH; van der Kwast TH; Kil PJ; Coebergh JW; Kiemeney LA
    Eur J Cancer; 2010 Jul; 46(11):2077-87. PubMed ID: 20471247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relative impact and future burden of prostate cancer in the United States.
    Chan JM; Jou RM; Carroll PR
    J Urol; 2004 Nov; 172(5 Pt 2):S13-6; discussion S17. PubMed ID: 15535436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012.
    Ondrusova M; Mrozova L; Ondrus D; Mrinakova B
    Neoplasma; 2013; 60(4):446-51. PubMed ID: 23581418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer incidence in Missouri: an updated analysis.
    Chang JC; Hagan RA; Malone BR
    Mo Med; 1995 Nov; 92(11):693-5. PubMed ID: 8569671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer.
    Alanee S; Moore A; Nutt M; Holland B; Dynda D; El-Zawahry A; McVary KT
    Anticancer Res; 2015 Jul; 35(7):4145-50. PubMed ID: 26124369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer in Canada.
    Estey EP
    In Vivo; 1994; 8(3):437-8. PubMed ID: 7803730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, mortality, and survival statistics for prostatic cancer.
    Byar DP
    Prog Clin Biol Res; 1987; 239():785-96. PubMed ID: 3658994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.